Latest Publications
Latest Publications (selected 10 publications in last 5 years)
1. Shekher A, Puneet, Awasthee N, Kumar U, Raj R, Kumar D, Gupta SC. Association of altered metabolic profiles and long non-coding RNAs expression with disease severity in Breast Cancer patients: Analysis by 1H NMR spectroscopy and RT-q-PCR. Metabolomics 19 (2023): 8. 2022 IF: 3.60.
2. Awasthee N, Shekher A, Rai V, Verma SS, Mishra S, Dhasmana A, Gupta SC. Piperlongumine, a piper alkaloid, enhances the efficacy of doxorubicin in breast cancer: Involvement of glucose import, ROS, NF-κB and lncRNAs. Apoptosis 27 (2022): 261-282. 2022 IF: 7.20.
3. Shekher A, Tiwari AK, Awasthee N, Verma SS, Dixit VK, Sinha N, Gupta SC, Puneet. Genes involved in phosphatidylcholine biosynthesis correlate with nuclear factor-kB in biliary tract cancer patients: Evidence from 1H-NMR and computational analyses. Biochimica et Biophysica Acta-Molecular and Cell Biology of Lipids 1866 (2021): 158970. 2022 IF: 4.80.
4. Aggarwal S, Verma SS, Aggarwal S, Gupta SC. Drug repurposing for breast cancer therapy: Old weapon for new battle. Seminars in Cancer Biology 68 (2021): 8-20. 2022 IF: 14.50.
5. Rai V, Aggarwal SK, Verma SS, Awasthee N, Dhasmana A, Aggarwal S, Das SN, Nair MS, Yadav S, Gupta SC. Epoxyazadiradione exhibits activities in head and neck squamous cell carcinoma by targeting multiple pathways. Apoptosis 25 (2020): 763-782. 2022 IF: 7.20.
6. Chava S, Reynolds PC, Pathania A, Gorantla S, Poluektova LY, Coulter DW, Gupta SC, Pandey MK, Challagundla KB. miR-15a-5p, miR-15b-5p, and miR-16-5p inhibit tumor progression by directly targeting MYCN in neuroblastoma. Molecular Oncology 14 (2020): 180-196. 2022 IF: 6.60.
7. Gupta SC, Awasthee N, Rai V, Gunda V, Chava S, Challagundla KB. Long non-coding RNAs and nuclear factor-kB crosstalk in cancer and other human diseases. Biochimica et Biophysica Acta-Reviews on Cancer 1873 (2020): 188316. 2022 IF: 11.20.
8. Verma SS, Rai V, Awasthee N, Dhasmana A, Rajalaksmi DS, Nair MS, Gupta SC. Isodeoxyelephantopin, a sesquiterpene lactone induces ROS generation, suppresses NF-kB activation, modulates lncRNA expression and exhibit activities against breast cancer. Scientific Reports 9 (2019): 17980. 2022 IF: 4.60.
9. Mishra S, Verma SS, Rai V, Awasthee N, Arya J, Maiti KK, Gupta SC. Curcuma raktakanda induces apoptosis and suppresses migration in cancer cells: Role of reactive oxygen species. Biomolecules 9 (2019): 4. 2022 IF: 5.50.
10. Awasthee N, Rai V, Verma SS, Francis KS, Nair MS, Gupta SC. Anti-cancer Activities of Bharangin Against Breast Cancer: Evidence for the Role of NF-kB and lncRNAs. Biochimica et Biophysica Acta-General Subjects 1862 (2018): 2738–2749. 2022 IF: 3.00.
Books
1. Clinical applications of non-coding RNAs in cancer. Publisher: Elsevier Inc; 2021; in press.
2. Anti-inflammatory Nutraceuticals and Chronic Diseases. Series: Advances in Experimental Medicine and Biology; Publisher: Springer; 2016; Page 1-479.
3. Drug Discovery from Mother Nature. Series: Advances in Experimental Medicine and Biology; Publisher: Springer; 2016; Page 1-407.
4. Inflammation and Cancer. Series: Advances in Experimental Medicine and Biology; Publisher: Springer; 2014; Page 1-490.
Book chapters
1. Awasthee N, Shekher A, Rai V, Baruah PK, Sharma A, Challagundla KB, Gupta SC. Clinical significance of long non-coding RNAs in breast cancer patients. In: Clinical applications of non-coding RNAs in cancer, edited by Gupta SC, Challagundla KB, Elsevier Inc., Cambridge, MA, USA, 2021, in press.
2. Pathania AS, Smith OV, Prathipati P, Gupta SC, Challagundla KB. Clinical implications of non-coding RNAs in neuroblastoma patients. In: Clinical applications of non-coding RNAs in cancer, edited by Gupta SC, Challagundla KB, Elsevier Inc., Cambridge, MA, USA, 2021, in press.
3. Chauhan HS, Rai V, Kini S, Shekher A, Sharma A, Gupta SC. Potential of long non-coding RNAs in the diagnosis and therapy of melanoma skin cancer. In: Skin cancer: Pathogenesis and Diagnosis, edited by Dwivedi A, Tripathi A, Ray RS, Singh AK, Springer Nature Singapore Pte Ltd, Singapore, 2021, in press.
4. Dwivedi S, Verma SS, D’Souza C, Awasthi N, Sharma A, Gupta SC. Potential of Small Animals in Toxicity Testing: Hope from Small World. In: Biomarkers in Toxicology 2e, edited by Gupta RC, Elsevier Inc., San Diego, USA, 2019, Chapter 7, pp 129-142.
5. Verma SS, Rai V, Shukla KK, Gupta SC. Regulation of non-coding RNAs by phytochemicals for cancer therapy. In: Nutritional Epigenomics, edited by Ferguson BS, Elsevier Inc., San Diego, USA, 2019, Chapter 22, pp 371-380.
6. Sharma A, D’Souza C, Rai V, Gupta SC. Evaluation of safety and efficacy of nutraceuticals using Drosophila as an in vivo tool. In: Nutraceuticals in Veterinary Medicine, edited by Gupta R, Srivastava A, Lall R, Springer Press, Spring Street, NY, USA, 2019, pp 685-692.
7. Gupta SC, Sharma A, Mishra S, Awasthee N. Nutraceuticals for the Prevention and Cure of Cancer. In: Nutraceuticals in Veterinary Medicine, edited by Gupta R, Srivastava A, Lall R, Springer Press, Spring Street, NY, USA, 2019, pp 603-610.
8. Mishra S, Rai V, Kumar A, Aggarwal SK, Gupta SC. Molecular diagnostics in pancreatic cancer. In: Molecular Diagnostics in Cancer Patients, edited by Shukla K, Sharma P, Misra S, Springer Nature Singapore, 2019, pp 157-163.
9. Gupta SC, Rai V. Role of Emodin in Chemosensitization of Cancer. In: Role of Nutraceuticals in Cancer Chemosensitization, edited by Bharti AC and Aggarwal BB, Elsevier Inc., Philadelphia, USA, 2018, Chapter 12, pp 241-257.
10. Gupta SC, Kim JH, Prasad S, Aggarwal BB. Chronic inflammation and cancer: a matter of lifestyle. In: Chronic Inflammation: Molecular Pathophysiology, Nutritional and Therapeutic Interventions, edited by Roy S, Bagchi D, Raychaudhuri SP. CRC Press, Taylor and Francis Group, Boca Raton, NY, 2012, pp. 153-171.
.png)
